Demographic and clinical characteristics of participants who likely have chronic pain and those who likely do not have chronic pain
Participant characteristics . | Chronic pain (n = 14) N (%) . | No chronic pain (n = 19) N (%) . | P value . |
---|---|---|---|
Age (median, IQR) | 36 (23-36) | 29 (30.5-44) | .042∗ |
Sex, female | 7 (50.0) | 8 (42.1) | .65† |
Genotype | |||
HbSS | 7 (50.0) | 14 (73.6) | .364† |
HbSC | 6 (42.9) | 4 (21.1) | |
HbSβ+ | 1 (7.1) | 1 (5.3) | |
Hydroxyurea use | 9 (64.3) | 17 (89.4) | .106† |
Taking at least 1 type of opioid | 12 (85.7) | 13 (68.4) | .416† |
Taking acetaminophen, ibuprofen, or naproxen | 7 (50.0) | 14 (73.7) | .459† |
Treated for pain in the hospital or clinic in the past 3 months | 11 (78.6) | 7 (36.8) | .017† |
Pain frequency in a typical month | |||
No pain at all | 0 | 3 (15.8) | N/A |
1-2 times a month | 0 | 9 (47.4) | |
1-2 times a week | 0 | 5 (26.3) | |
More than 10 times a month | 2 (14.3) | 1 (5.3) | |
3-4 times a week | 4 (28.6) | 0 | |
5-6 times a week | 0 | 1 (5.3) | |
Everyday | 8 (57.1) | 0 |
Participant characteristics . | Chronic pain (n = 14) N (%) . | No chronic pain (n = 19) N (%) . | P value . |
---|---|---|---|
Age (median, IQR) | 36 (23-36) | 29 (30.5-44) | .042∗ |
Sex, female | 7 (50.0) | 8 (42.1) | .65† |
Genotype | |||
HbSS | 7 (50.0) | 14 (73.6) | .364† |
HbSC | 6 (42.9) | 4 (21.1) | |
HbSβ+ | 1 (7.1) | 1 (5.3) | |
Hydroxyurea use | 9 (64.3) | 17 (89.4) | .106† |
Taking at least 1 type of opioid | 12 (85.7) | 13 (68.4) | .416† |
Taking acetaminophen, ibuprofen, or naproxen | 7 (50.0) | 14 (73.7) | .459† |
Treated for pain in the hospital or clinic in the past 3 months | 11 (78.6) | 7 (36.8) | .017† |
Pain frequency in a typical month | |||
No pain at all | 0 | 3 (15.8) | N/A |
1-2 times a month | 0 | 9 (47.4) | |
1-2 times a week | 0 | 5 (26.3) | |
More than 10 times a month | 2 (14.3) | 1 (5.3) | |
3-4 times a week | 4 (28.6) | 0 | |
5-6 times a week | 0 | 1 (5.3) | |
Everyday | 8 (57.1) | 0 |